A Review on Mucoadhesive Buccal Film of Prochlorperazine Mesylate

Read full text Summarise with VIRAT
Authors: Drashti Patel*, Mona Gupta, Dr. Pankaj Prajapati
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Prochlorperazine Mesylate is a widely used antiemetic and antipsychotic drug; however, its conventional oral administration is associated with limitations such as first-pass metabolism, reduced bioavailability, and delayed onset of action. Mucoadhesive buccal drug delivery systems have emerged as a promising alternative for overcoming these challenges by allowing direct drug absorption through the buccal mucosa into systemic circulation. This review focuses on the development and potential of Mucoadhesive buccal films of Prochlorperazine Mesylate as an effective drug delivery system. The article highlights the principles of buccal drug delivery, mechanisms of drug absorption through the buccal mucosa, and the role of mucoadhesion in enhancing drug residence time and bioavailability. Various formulation components, including polymers, plasticizers, and penetration enhancers, along with commonly used preparation methods such as solvent casting, are discussed. Additionally, important evaluation parameters of buccal films are summarized. Overall, mucoadhesive buccal films represent a promising, non-invasive, and patient-friendly approach for improving therapeutic efficacy and compliance.

Fields of Study & Subjects

Advanced Drug Delivery Systems Drug Solubulity and Delivery Systems Advancements in Transdermal Drug Delivery

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
27 March 2026
Language
EN